The global needle-free injectors market size was estimated to be US$ 5.7 billion in 2020
The needle-free injector market is expected to grow at a CAGR of 15.5% between 2022 and 2032.
Endo International plc (United Kingdom), PharmaJet (United States), Bioject Medical Technologies Inc. (United States), Medical International Technology, Inc. (United States), INJEX Pharma AG (Germany), National Medical Products Inc. (United States), Valeritas, Inc. (United States), European Pharma Group (Netherlands), PenJet Corporation (United States), Crossject SA (United Kingdom), European Pharma Group (Netherlands), Pen (France)
North America is the prominent geography of needle-free injectors market
The needle-free injectors market is being driven by rising demand for self-injection devices, advanced medical infrastructure, a growing geriatric population, rising prevalence of chronic and infectious diseases, lack of reusability of traditional needles, rising healthcare expenditures, and the rising need for vaccination.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved